Financhill
Buy
57

RDN Quote, Financials, Valuation and Earnings

Last price:
$33.98
Seasonality move :
18.97%
Day range:
$33.71 - $34.14
52-week range:
$29.32 - $37.86
Dividend yield:
2.94%
P/E ratio:
8.65x
P/S ratio:
4.01x
P/B ratio:
1.00x
Volume:
1.3M
Avg. volume:
1.3M
1-year change:
-2.44%
Market cap:
$4.6B
Revenue:
$1.3B
EPS (TTM):
$3.93
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.4B $1.3B $1.2B $1.2B $1.3B
Revenue Growth (YoY) -5.79% -7.56% -10.47% 4.19% 4.01%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- $367.5M
Other Inc / (Exp) $3.6M $3.4M $2.5M $6.2M $6.2M
Operating Expenses $285.9M $327.1M $385.5M $343.3M $343.6M
Operating Income -- -- -- -- --
 
Net Interest Expenses $71.2M $84.3M $84.5M $89.7M $103.7M
EBT. Incl. Unusual Items $479.4M $764.8M $952.8M $767.5M $771.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $85.8M $164.2M $209.8M $164.4M $166.9M
Net Income to Company $393.6M $600.7M $742.9M $603.1M $604.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $393.6M $600.7M $742.9M $603.1M $604.4M
 
Basic EPS (Cont. Ops) $2.01 $3.19 $4.42 $3.81 $3.96
Diluted EPS (Cont. Ops) $2.00 $3.16 $4.35 $3.77 $3.92
Weighted Average Basic Share $195.4M $188.4M $167.9M $158.1M $152.5M
Weighted Average Diluted Share $196.6M $190.3M $170.7M $160.1M $154.2M
 
EBITDA -- -- -- -- --
EBIT $550.6M $849.2M $1B $857.2M $875M
 
Revenue (Reported) $1.4B $1.3B $1.2B $1.2B $1.3B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $550.6M $849.2M $1B $857.2M $875M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $328.8M $293M $309.9M $319.4M $317.7M
Revenue Growth (YoY) -0.08% -10.9% 5.76% 3.09% -0.54%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- $82.7M
Other Inc / (Exp) $976K $703K $1.6M $1.3M $1M
Operating Expenses $71.1M $90.4M $84.6M $78.4M $76.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses $21.1M $20.8M $21.4M $24.8M $22.5M
EBT. Incl. Unusual Items $161.2M $234.1M $204M $198.6M $188.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $35.6M $53M $46.3M $46.3M $43.9M
Net Income to Company -- -- -- $152.4M $144.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $125.6M $181.1M $157.8M $152.4M $144.6M
 
Basic EPS (Cont. Ops) $0.65 $1.02 $1.00 $0.99 $0.99
Diluted EPS (Cont. Ops) $0.64 $1.01 $0.98 $0.98 $0.98
Weighted Average Basic Share $193.4M $176.8M $158.3M $153.8M $145.6M
Weighted Average Diluted Share $195.2M $179.1M $161.3M $156M $147.7M
 
EBITDA -- -- -- -- --
EBIT $182.3M $255M $225.5M $223.4M $210.9M
 
Revenue (Reported) $328.8M $293M $309.9M $319.4M $317.7M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $182.3M $255M $225.5M $223.4M $210.9M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.4B $1.3B $1.2B $1.3B $1.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $3.8M $3.1M $3.3M $5.9M $5.9M
Operating Expenses $286.9M $346.4M $379.7M $337M $342.1M
Operating Income -- -- -- -- --
 
Net Interest Expenses $80.1M $84.1M $85M $93M $101.5M
EBT. Incl. Unusual Items $459.3M $837.8M $922.7M $762.1M $761.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $80.6M $181.6M $203.1M $164.4M $164.4M
Net Income to Company -- -- -- $755.5M $596.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $378.8M $656.2M $719.6M $597.7M $596.6M
 
Basic EPS (Cont. Ops) $1.97 $3.58 $4.41 $3.82 $3.97
Diluted EPS (Cont. Ops) $1.95 $3.55 $4.34 $3.78 $3.93
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT $539.4M $921.9M $1B $855.2M $862.5M
 
Revenue (Reported) $1.4B $1.3B $1.2B $1.3B $1.3B
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $539.4M $921.9M $1B $855.2M $862.5M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $328.8M $293M $309.9M $319.4M $317.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- $82.7M
Other Inc / (Exp) $976K $703K $1.6M $1.3M $1M
Operating Expenses $71.1M $90.4M $84.6M $78.4M $76.8M
Operating Income -- -- -- -- --
 
Net Interest Expenses $21.1M $20.8M $21.4M $24.8M $22.5M
EBT. Incl. Unusual Items $161.2M $234.1M $204M $198.6M $188.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $35.6M $53M $46.3M $46.3M $43.9M
Net Income to Company -- -- -- $152.4M $144.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $125.6M $181.1M $157.8M $152.4M $144.6M
 
Basic EPS (Cont. Ops) $0.65 $1.02 $1.00 $0.99 $0.99
Diluted EPS (Cont. Ops) $0.64 $1.01 $0.98 $0.98 $0.98
Weighted Average Basic Share $193.4M $176.8M $158.3M $153.8M $145.6M
Weighted Average Diluted Share $195.2M $179.1M $161.3M $156M $147.7M
 
EBITDA -- -- -- -- --
EBIT $182.3M $255M $225.5M $223.4M $210.9M
 
Revenue (Reported) $328.8M $293M $309.9M $319.4M $317.7M
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) $182.3M $255M $225.5M $223.4M $210.9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $87.9M $151.1M $56.2M $19M $38.8M
Short Term Investments $6.3B $6B $5.3B $5.7B $5.5B
Accounts Receivable, Net $194.5M $191.9M $145.5M $149.8M $164.5M
Inventory -- -- -- -- --
Prepaid Expenses $478.5M $555.8M $737.8M $850.8M $993.6M
Other Current Assets -- -- -- -- --
Total Current Assets $7.1B $6.9B $6.3B $6.7B $6.7B
 
Property Plant And Equipment $113.4M $107M $92.1M $63.8M $27.6M
Long-Term Investments $6.8B $6.5B $5.6B $5.9B $5.7B
Goodwill $9.8M $9.8M $9.8M -- --
Other Intangibles $13.2M $9.8M $5.5M -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $7.9B $7.8B $7.1B $7.6B $8.7B
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- $124M $137.3M $85.6M $36.1M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $124M $585.1M $1.1B $59.4M
 
Long-Term Debt $1.6B $1.4B $984.3M $480.3M $2.3B
Capital Leases -- -- -- -- --
Total Liabilities $3.7B $3.6B $3.1B $3.2B $4B
 
Common Stock $210K $194K $176K $173K $168K
Other Common Equity Adj $263.7M $120.1M -$456.8M -$330.9M -$350.2M
Common Equity $4.3B $4.3B $3.9B $4.4B $4.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.3B $4.3B $3.9B $4.4B $4.6B
 
Total Liabilities and Equity $7.9B $7.8B $7.1B $7.6B $8.7B
Cash and Short Terms $6.4B $6.2B $5.4B $5.7B $5.5B
Total Debt $1.6B $1.6B $1.6B $1.5B $2.3B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $102.8M $131.9M $50.2M $27M $24.2M
Short Term Investments $6.3B $5.9B $5.5B $5.8B $5.5B
Accounts Receivable, Net $210.7M $197.6M $154M $158.2M $168M
Inventory -- -- -- -- --
Prepaid Expenses $454.2M $535.5M $726.1M $842.6M $987.9M
Other Current Assets -- -- -- -- --
Total Current Assets $7B $6.8B $6.4B $6.9B $6.7B
 
Property Plant And Equipment $109.6M $105.2M $91.9M $75.7M $25.6M
Long-Term Investments $6.7B $6.3B $5.7B $6.1B $5.7B
Goodwill $9.8M $9.8M $9.8M -- --
Other Intangibles $12.4M $8.9M $4.1M -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $7.9B $7.6B $7.2B $7.8B $8.8B
 
Accounts Payable -- -- -- -- --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- $66.1M $60.7M $56.9M $22.4M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $66.1M $60.7M $952.9M $72.8M
 
Long-Term Debt $1.5B $1.5B $1.5B $767.6M $2.3B
Capital Leases -- -- -- -- --
Total Liabilities $3.7B $3.5B $3.1B $3.3B $4.2B
 
Common Stock $210K $193K $176K $171K $162K
Other Common Equity Adj $116.7M -$129.6M -$386.6M -$362.5M -$294.7M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.2B $4.1B $4.1B $4.4B $4.6B
 
Total Liabilities and Equity $7.9B $7.6B $7.2B $7.8B $8.8B
Cash and Short Terms $6.4B $6B $5.5B $5.9B $5.5B
Total Debt $1.5B $1.6B $1.5B $1.7B $2.4B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $393.6M $600.7M $742.9M $603.1M $604.4M
Depreciation & Amoritzation $71.7M $75.5M $76.6M $88.9M $78.8M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$85.5M $2.6M $46.5M -$1.9M -$12M
Change in Inventories -- -- -- -- --
Cash From Operations $658.4M $557.1M $388.3M $529.4M -$663.6M
 
Capital Expenditures $17M $12.6M $17.7M $16.3M $3.2M
Cash Acquisitions $16.5M -- -- -- --
Cash From Investing -$883.2M -$1.9M -$5.2M -$300.8M $327.7M
 
Dividends Paid (Ex Special Dividend) -$97.5M -$103.3M -$135.4M -$145.9M -$152M
Special Dividend Paid
Long-Term Debt Issued $722.6M $42M $381.9M $761.6M $3.6B
Long-Term Debt Repaid -$138M -$48M -$377M -$797.9M -$2.8B
Repurchase of Common Stock -$226.3M -$399.1M -$400.2M -$133.3M -$225.1M
Other Financing Activities -$2.3M -$3.3M -$814K -$904K -$812K
Cash From Financing $222.6M -$496.8M -$479.2M -$265.1M $357.2M
 
Beginning Cash (CF) $96.3M $94.1M $152.6M $56.6M $20.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.1M $58.5M -$96.1M -$36.5M $21.4M
Ending Cash (CF) $94.1M $152.6M $56.6M $20.1M $41.5M
 
Levered Free Cash Flow $641.4M $544.5M $370.6M $513.2M -$666.7M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders -- -- $303.8M $151.9M --
Depreciation & Amoritzation -- -- $32.8M $19.9M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -$15.5M -$10.3M --
Change in Inventories -- -- -- -- --
Cash From Operations $122.9M $60.2M $72.5M -$207.3M --
 
Capital Expenditures $2.9M $3.4M $5.3M $1.1M --
Cash Acquisitions -- -- -- -- --
Cash From Investing $5.5M $84.4M -$59.5M -$1M --
 
Dividends Paid (Ex Special Dividend) -$27.9M -$35.9M -$39.5M -$40.5M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $12.8M $10.2M $44M $253.8M --
Long-Term Debt Repaid -$14M $4.8M $11.6M $41.6M --
Repurchase of Common Stock -$90.1M -$167.9M -$5M -$50M --
Other Financing Activities -$237K -$191K -$281K -$140K --
Cash From Financing -$114.3M -$142.3M -$1.3M $195.3M --
 
Beginning Cash (CF) $123.8M $133.5M $50.7M $28.8M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $14.1M $2.3M $11.7M -$13M --
Ending Cash (CF) $137.9M $135.8M $62.5M $15.8M --
 
Levered Free Cash Flow $119.9M $56.8M $67.1M -$208.3M --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -- -- -- $755.5M $596.6M
Depreciation & Amoritzation -- -- -- $103.3M $78.8M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$10.6M -$6.1M
Change in Inventories -- -- -- -- --
Cash From Operations $655.7M $520.8M $388.4M $463.7M -$646.8M
 
Capital Expenditures $14.1M $14.6M $18.4M $13.1M $2.8M
Cash Acquisitions $612K -- -- -- --
Cash From Investing -$997.1M $8.3M $36.1M -$343.7M $507.4M
 
Dividends Paid (Ex Special Dividend) -$96.4M -$114.6M -$135.8M -$147.8M -$151.7M
Special Dividend Paid
Long-Term Debt Issued $681.8M $25.8M $389.5M $1.7B $3.3B
Long-Term Debt Repaid -$134.1M -$32.8M -$417M -$1.5B -$2.7B
Repurchase of Common Stock -$8.6M -$409.5M -$396.2M -$168.3M -$384M
Other Financing Activities -$2.3M -$3.3M -$818K -$853K -$816K
Cash From Financing $403.3M -$519.3M -$507.2M -$141.9M $139M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $61.8M $9.7M -$82.8M -$21.9M -$476K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $641.5M $506.2M $370M $450.6M -$649.6M
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Net Income to Stockholders -- -- $303.8M $304.3M $144.6M
Depreciation & Amoritzation -- -- $32.8M $34.3M $14.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -$15.5M -$19M -$2.8M
Change in Inventories -- -- -- -- --
Cash From Operations $275.9M $176.9M $189.2M -$156.2M $67.8M
 
Capital Expenditures $5M $7.5M $10.1M $2.6M $1.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$76.4M $12.6M -$90M -$74.4M $106.2M
 
Dividends Paid (Ex Special Dividend) -$52M -$71.3M -$75.2M -$78.1M -$37.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $32M $13.2M $54.6M $1.2B $689.8M
Long-Term Debt Repaid -$42M -$8M -$41.1M -$695.8M -$641.1M
Repurchase of Common Stock -$98.7M -$186.9M -$20M -$100M -$208.9M
Other Financing Activities -$471K -$380K -$474K -$282K -$146K
Cash From Financing -$155.7M -$206.3M -$93.3M $226.4M -$187.2M
 
Beginning Cash (CF) $217.9M $286.1M $107.3M $48.9M $41.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $43.8M -$16.8M $5.9M -$4.3M -$13.1M
Ending Cash (CF) $261.7M $269.3M $113.2M $44.6M $28.4M
 
Levered Free Cash Flow $270.9M $169.4M $179.1M -$158.9M $66.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
68
MCRI alert for Jul 18

Monarch Casino & Resort [MCRI] is up 19.81% over the past day.

Sell
41
NEGG alert for Jul 18

Newegg Commerce [NEGG] is up 17.85% over the past day.

Buy
72
MNPR alert for Jul 18

Monopar Therapeutics [MNPR] is up 13.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock